Literature DB >> 18548342

Expression of human papilloma virus type 16 antigens, specific targeting as well as formation of virus-like particles by HSV-1 amplicon vectors.

Sabine Schenck1, Elke Kehm, Alberto L Epstein, Hanswalter Zentgraf, Martin Müller, Charles W Knopf.   

Abstract

Expression of human papilloma virus type 16 (HPV16) antigens by herpes simplex virus type 1 (HSV-1)-based amplicon vectors was investigated. Amplicons were packaged using HSV-1 LaL, a virus with a floxed 'a' sequence, and the CRE recombinase-expressing cell line TE-CRE30. In amplicon-infected BHK-21 cells, a 60-mer E7 peptide was weakly expressed, but its expression was significantly improved using a transcription unit with humanized codons. In contrast, the HPV16 structural proteins L1 and L2, as well as L1 fusion proteins with E7, were expressed at high levels. L1 displayed nuclear and cytoplasmic localization, and L1-E7 fusion proteins with a synthetic nuclear localization signal (NLS) from simian virus 40 (SV40) accumulated in the nuclei. The self-assembly of L1 into virus-like particles (VLPs) in HSV-1 amplicon-infected cells was confirmed by electron microscopy and a specific antigen-capture ELISA. For targeting of herpes virions with HPV16 antigens, a 60-mer E7 peptide was fused to the herpesviral tegument protein VP22 and envelope glycoprotein C (gC). Both fusion proteins, VP22E7 and gCE7, were demonstrated to be associated with sucrose gradient-purified infectious HSV-1 virion particles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18548342     DOI: 10.1007/s11262-008-0247-8

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  40 in total

Review 1.  Vaccine developments.

Authors:  M A Liu
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

2.  Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

Authors:  X S Chen; G Casini; S C Harrison; R L Garcea
Journal:  J Mol Biol       Date:  2001-03-16       Impact factor: 5.469

3.  Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination.

Authors:  Nico Michel; Wolfram Osen; Lutz Gissmann; Ton N M Schumacher; Hanswalter Zentgraf; Martin Müller
Journal:  Virology       Date:  2002-03-01       Impact factor: 3.616

4.  An infectious transfer and expression system for genomic DNA loci in human and mouse cells.

Authors:  R Wade-Martins; E R Smith; E Tyminski; E A Chiocca; Y Saeki
Journal:  Nat Biotechnol       Date:  2001-11       Impact factor: 54.908

5.  The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein.

Authors:  D Smotkin; F O Wettstein
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

6.  Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.

Authors:  Peter Ohlschläger; Wolfram Osen; Kerstin Dell; Stefan Faath; Robert L Garcea; Ingrid Jochmus; Martin Müller; Michael Pawlita; Klaus Schäfer; Peter Sehr; Caroline Staib; Gerd Sutter; Lutz Gissmann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Codon optimization for high-level expression of human erythropoietin (EPO) in mammalian cells.

Authors:  C H Kim; Y Oh; T H Lee
Journal:  Gene       Date:  1997-10-15       Impact factor: 3.688

8.  Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes.

Authors:  C Leder; J A Kleinschmidt; C Wiethe; M Müller
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Nuclear localization and transforming activity of human papillomavirus type 16 E7-beta-galactosidase fusion protein: characterization of the nuclear localization sequence.

Authors:  K Fujikawa; M Furuse; K Uwabe; H Maki; O Yoshie
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

Review 10.  HSV-1 amplicon vectors: a promising and versatile tool for gene delivery.

Authors:  Delphine Cuchet; Corinne Potel; Joélle Thomas; Alberto L Epstein
Journal:  Expert Opin Biol Ther       Date:  2007-07       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.